News tagged with therapeutic option
Transplanted genetically-modified adipose cells offer potential therapy for liver diseases
Using mesenchymal stromal cells derived from adipose (fat) tissues, genetically modified to express a bioluminescent marker, researchers in Italy have tracked cells after transplantation. The cells were followed from their ...
Medical research
Dec 20, 2012 |
5 / 5 (1) |
0
New clinical recommendations for diagnosing and treating stable ischemic heart disease
Six organizations representing physicians, other health care professionals, and patients today issued two new clinical practice guidelines for diagnosing and treating stable ischemic heart disease (IHD), which affects an ...
Cardiology
Nov 19, 2012 |
3 / 5 (1) |
0
Preclinical muscular dystrophy data shows promise
Cedars-Sinai Heart Institute researchers have found that an experimental compound may help stem the debilitating effects of muscular dystrophy by restoring normal blood flow to muscles affected by the genetic disorder.
Medical research
Nov 08, 2012 |
4 / 5 (1) |
0
|
Hedgehog pathway key in tamoxifen-resistant breast CA
(HealthDay)—Noncanonical Hedgehog (Hh) signaling is activated in tamoxifen-resistant tumors, and the phosphoinositide 3-kinase inhibitor/protein kinase B (PI3K/AKT) pathway plays a key role protecting Hh ...
Cancer
Nov 06, 2012 |
not rated yet |
0
Stereotactic radiosurgery shows promise for kidney cancer
A first-of-its-kind clinical trial conducted at University Hospitals (UH) Case Medical Center Seidman Cancer Center has shown encouraging results for the use of stereotactic radiosurgery to treat kidney cancer. This non-invasive ...
Cancer
Oct 31, 2012 |
not rated yet |
0
Study adds to efforts to find more effective anti-inflammatory drugs
Researchers have discovered a previously unknown function for a protein that could add to the expanding arsenal of potential new drugs for battling inflammation and tissue fibrosis in a number of disease processes.
Inflammatory disorders
Sep 27, 2012 |
not rated yet |
0
|
Drug combination against NRAS-mutant melanoma discovered
A new study published online in Nature Medicine, led by scientists at The University of Texas MD Anderson Cancer Center, describes the discovery of a novel drug combination aimed at a subset of melanoma patients who curren ...
Cancer
Sep 17, 2012 |
5 / 5 (1) |
0
|
Among new HIV treatment recommendations, all adult patients should be offered antiretroviral therapy
Included in the 2012 International Antiviral Society-USA panel recommendations for human immunodeficiency virus (HIV) patient care is that all adult patients, regardless of CD4 cell count, should be offered antiretroviral ...
HIV & AIDS
Jul 22, 2012 |
not rated yet |
0
Preclinical data support ongoing clinical trials testing IDO inhibitors as a treatment for cancer
Inhibitors of indoleamine 2,3-dioxygenase (IDO) are being assessed in clinical trials as a potential treatment for recurrent or refractory solid tumors. Clear genetic rationale for these trials, together with evidence that ...
Cancer
Jul 19, 2012 |
not rated yet |
0
Platelet drug shows clinical benefits for severe, unresponsive aplastic anemia
Eltrombopag, a drug that was designed to stimulate production of platelets from the bone marrow and thereby improve blood clotting, can raise blood cell levels in some people with severe aplastic anemia who have failed all ...
Diseases, Conditions, Syndromes
Jul 04, 2012 |
5 / 5 (2) |
0
|
Mount Sinai researcher finds timing of ADHD medication affect academic progress
A team of researchers led by an epidemiologist at Mount Sinai School of Medicine and University of Iceland has found a correlation between the age at which children with attention-deficit/hyperactivity disorder (ADHD) begin ...
Attention deficit disorders
Jun 25, 2012 |
not rated yet |
1
|
Researchers review muscular dystrophy therapies
Leading muscular dystrophy researcher Dean Burkin, of the University of Nevada School of Medicine summarizes the impact of a new protein therapeutic, MG53, for the treatment of Duchenne muscular dystrophy ...
Medical research
Jun 22, 2012 |
4 / 5 (1) |
0
|
Want to avoid ED following prostate cancer surgery? Find an experienced, gentle surgeon
Prostate cancer is the most commonly diagnosed non-skin cancer in the U.S., and radical prostatectomy, the surgical removal of the prostate gland, remains the most popular therapeutic option, accounting for ...
Surgery
May 16, 2012 |
not rated yet |
0
|
Targeted therapeutics for colon cancer to be presented at AACR meeting
Anurag Singh, PhD, assistant professor in the Department of Pharmacology and Experimental Therapeutics at Boston University School of Medicine has been invited to present his recent work on targeted therapeutics for colon ...
Cancer
Apr 04, 2012 |
not rated yet |
0
Scientists discover in studies with mice that an anti-cancer gene also fights obesity
Researchers from the Spanish National Cancer Research Centre working with mice have revealed that one of the main genes protecting against cancer brings two additional health benefits by boosting longevity and combating obesity. ...
Cancer
Mar 06, 2012 |
5 / 5 (2) |
0
